RIFAXIMIN INDUCED HYPONATREMIA: A CASE REPORT by Agrawal, Prabhat et al.
Online - 2455-3891 
Print - 0974-2441Vol 9, Suppl. 3, 2016
RIFAXIMIN INDUCED HYPONATREMIA: A CASE REPORT
PRABHAT AGRAWAL1, MANISH BANSAL1, SHALINI UPADHYAY1*, ANJALIKA GUPTA2
1Department of Medicine, SNMC, Agra, India. 2Department of Medicine, BM Gupta Hospital, Delhi, India. Email:ushalini19@yahoo.com
Received: 02 August 2016, Revised and Accepted: 10 September 2016
ABSTRACT
Rifaximin is one of the common drugs used in clinical practice in the management of traveler’s diarrhea, irritable bowel syndrome (IBS), and hepatic 
encephalopathy. Hyponatremia is one of the rare side effects of this drug. We hereby present the case of a middle-aged woman who was a known case 
of IBS: Diarrhea predominant who developed symptoms of hyponatremia after a short duration of rifaximin treatment, no other cause of hyponatremia 
was found on evaluation, so we suspect this as a rare side effect of rifaximin therapy.
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INTRODUCTION
Rifaximin is a semi synthetic antibiotic which is used in the treatment 
of traveler’s diarrhea [1], IBS [2], and hepatic encephalopathy [3]. Some 
common side effects of this drug are nausea, vomiting, rectal tenesmus, 
abdominal pain, defecation urgency, nausea, and constipation. One 
of the rare metabolic side effects of this drug is hyponatremia which 
can manifest as malaise, lethargy, decreased level of consciousness, 
headache, and seizures and coma.
CASE REPORT
A 35-year-old female was brought to emergency department with 
drowsiness for 2 days; on enquiry it was found that she is a known case of 
irritable bowel syndrome (IBS): Diarrhea predominant from 6 to 7 years.
Recently, she was advised tablet Rifaximin 550 mg BD by a private 
practitioner and she was taking it for last 5-6 days. However, for past 
2 days, her family members noticed she was unusually drowsy and 
she has been brought to our department for the same complaints, on 
further evaluation her vitals were stable. On general examination, 
there was mild pallor and rest were normal, cardiovascular system, 
gastrointestinal tract, and respiratory system were normal, pt was 
drowsy but oriented to time, place and person, planter was bilateral 
flexor, meningeal signs were absent, reflex, power was normal. 24 hrs 
output was approximately 2 l. On laboratory examination routine blood 
investigations complete blood count (Hb-8.2, TLC-6200, differential 
leukocyte count-neutrophils 82%, lymphocyte 18%, platelets 
2,20,000, ESR-44), liver function test (serum glutamic oxaloacetic 
transaminase-22, serum glutamic-pyruvic transaminase-44), and 
kidney function test (serum creatnine-0.9, blood urea-34 mg/dl) were 
unremarkable except serum electrolytes (serum Na+=118 meq/l; 
S.K+=4.5; serum Ca++=1.02). Plasma osmolarity came out to be 
255 mOsm/L, urine osmolarity was 112 mOsm/L and urinary (Na+) 
was 8 mEq/L. Viral markers (HIV/HbsAg/Anti-HCV) were negative. 
Computerized tomography scan brain was normal. She was managed 
conservatively with hypertonic saline (3% NaCl) and patient improved 
on the 2nd day of treatment, and patient was discharged on the 3rd day 
with S. Na+ 135 meq/l.
DISCUSSION
Rifaximin is a newer antibiotic which provides symptomatic 
improvement in IBS [4] such as bloating, flatulence, stool consistency, 
and abdominal pain. It acts by reducing the quantity of gas-producing 
bacteria and altering the predominant species of bacteria present, 
reducing mucosal inflammation, and visceral hypersensitivity [4]. 
There are many nonlife-threatening side effects of this drug, one of 
the rare side effects is hyponatremia, other drugs Which commonly 
causes hyponatremia are diuretics, antipsychotics, antidepressants 
(phenothiazine), tricyclic antidepressant, antiepileptics (oxcarbazepine, 
lamotrigine) cyclophosphamide, desmopressin, octreotide, vincristine, 
mannitol, etc.
In our patient, hyponatremia was considered as a cause of her drowsiness 
and after ruling out all other common causes of hyponatremia in our 
patient, rifaximin seems to be the incriminating cause. We are reporting 
this case because of the rarity of the same and probably this is the first 
published case of rifaximin induced hyponatremia.
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